Trimix ST-1 30PA-1.5PH-50A Aqueous Solution Pharm D Solutions, Houston, Texas --- NDC 69699-1388-05
Pharm D Solutions
Lack of Assurance of Sterility
Prescription and over-the-counter medications
Pharm D Solutions
Lack of Assurance of Sterility
Defective Container: Repetitive complaints received indicating pump not working.
Failed Impurities/Degradation Specifications:Out of specification result noticed for total impurities observed during stability analysis
Valeant Pharmaceuticals North America
CGMP deviations: Notice received from supplier of a voluntary recall of all their nasal products and baby oral gels due to the possibility of microbial contamination. No positive results for the firm's products. were obtained. After the firm review, cGMP deviations ere evident.
Lack of assurance of sterility: loss of container integrity.
Heritage Pharmaceuticals
Lack of Assurance of Sterility: complaints received about dried powder on the outside of the bottle
Subpotent drug: During testing of the retention sample, the firm discovered that the product was sub-potent.
Westlab Pharmacy, Inc.
Lack of Process Controls
Defective Delivery System: There is a potential for some tablets to be missing the laser drilling which might affect drug release.
Valeant Pharmaceuticals North America
CGMP deviations: Notice received from supplier of a voluntary recall of all their nasal products and baby oral gels due to the possibility of microbial contamination. No positive results for the firm's products. were obtained. After the firm review, cGMP deviations ere evident.
Failed dissolution specifications: Out-of-Specification dissolution test result obtained during routine stability testing.
Lack of Process Controls
Defective Delivery System: There is a potential for some tablets to be missing the laser drilling which might affect drug release.
CGMP Deviations: Detection of trace amounts of NDMA, a possible impurity or contaminant in an active pharmaceutical ingredient.
Defective Delivery System: There is a potential for some tablets to be missing the laser drilling which might affect drug release.
CGMP Deviations: cleaning procedures during manufacturing caused out of specification results for unknown impurities.
Westlab Pharmacy, Inc.
Incorrect Product Formulation
Defective Delivery System: There is a potential for some tablets to be missing the laser drilling which might affect drug release.
Defective Delivery System: There is a potential for some tablets to be missing the laser drilling which might affect drug release.
Upsher Smith Laboratories
Failed impurities/ degradation specifications: Product is Out of Specification for an unspecified degradation product.